CUSIP: G0750W104
Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,419,312
-
Share change
-
-3,371,827
-
Total reported value
-
$25,807,515
-
Put/Call ratio
-
210%
-
Price per share
-
$2.26
-
Number of holders
-
64
-
Value change
-
-$5,699,072
-
Number of buys
-
34
-
Number of sells
-
49
Quarterly Holders Quick Answers
What is CUSIP G0750W104?
CUSIP G0750W104 identifies AXGT - AXOVANT SCIENCES LTD - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2018
-
Previous quarter:
Q1 2018
Recent filing periods for CUSIP G0750W104:
Institutional Holders of AXOVANT SCIENCES LTD - COM (AXGT) as of Q2 2018
As of 30 Jun 2018,
AXOVANT SCIENCES LTD - COM (AXGT) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,419,312 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, Hudson Bay Capital Management LP, Connor, Clark & Lunn Investment Management Ltd., Marshall Wace North America L.P., TWO SIGMA INVESTMENTS, LP, and MORGAN STANLEY.
This page lists
64
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.